drugset / Trial / NCT01716221
An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
RandomizedCrossoverTriple-blindSupportive care
Summary
The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 50 mg | Oral |
| Subject | Bupropion | Small molecule | 100 mg | Oral |
| Subject | Citalopram | Small molecule | 10 mg | Oral |
| Subject | Citalopram | Small molecule | 20 mg | Oral |